Erectile dysfunction is the persistent difficulty of achieving or maintaining an erection suitable for sexual activity. Vilitra is an oral tablet product used in the treatment context of adult male…
Erectile dysfunction is the persistent difficulty of achieving or maintaining an erection suitable for sexual activity. Vilitra is an oral tablet product used in the treatment context of adult male erectile dysfunction, where increased penile blood flow during sexual stimulation is needed.
Vilitra is supplied as tablets for oral use. Vardenafil is the active pharmaceutical substance associated with this treatment category and belongs to the phosphodiesterase type 5 inhibitor class. The class promotes smooth-muscle relaxation in penile blood vessels, allowing greater blood flow when sexual stimulation releases nitric oxide.
The European Medicines Agency describes PDE5 inhibition as a targeted approach to erectile dysfunction rather than a treatment that raises testosterone or directly increases sexual desire [1].
A PDE5 inhibitor such as vardenafil works on the vascular pathway involved in penile erection, but the regimen for the chosen Vilitra strength should be confirmed with a healthcare professional before starting.
In clinical practice, erectile dysfunction that appears suddenly, worsens quickly, or occurs with chest discomfort deserves medical assessment because it may accompany cardiovascular disease.
Vilitra is supplied as tablets for oral use. Vardenafil is the active pharmaceutical substance associated with this treatment category and belongs to the phosphodiesterase type 5 inhibitor class. PDE5 inhibition promotes smooth-muscle relaxation in penile blood vessels, allowing greater blood flow during sexual stimulation.
Sexual stimulation activates parasympathetic nerve signals in penile tissue. These signals promote nitric oxide release. Nitric oxide then increases cGMP inside the smooth muscle of the corpora cavernosa, the erectile tissues of the penis.
cGMP relaxes the smooth muscle and widens local blood vessels. Blood enters the corpora cavernosa more readily, while pressure within the erectile tissue helps restrict venous outflow. The result is an erection that can be maintained during sexual activity.
PDE5 gradually breaks down cGMP. Vardenafil inhibits PDE5, so cGMP remains active for longer. This is why the medicine can improve the physical response to stimulation without causing an erection in the absence of sexual arousal.
The effect is vascular rather than hormonal. It does not permanently correct the underlying cause of erectile dysfunction, and it does not protect against sexually transmitted infections.
The FDA prescribing information for vardenafil describes PDE5 inhibition, vasodilation, and the requirement for sexual stimulation in the erection response [2].
The regimen for the chosen Vilitra strength should be confirmed with a healthcare professional before starting.
A heavy or very fatty meal may delay the onset of some PDE5 inhibitors. A lighter meal may provide more predictable timing. Large quantities of alcohol can also make erection problems worse and increase dizziness.
Do not take Vilitra together with another PDE5 inhibitor. Combining medicines from the same class does not reliably improve the erection and can increase the risk of low blood pressure and adverse effects.
Comparison by active substance is more useful than comparison by brand name. These medicines share a basic mechanism, yet their onset, duration, food effects, and tolerability can differ.
| Active substance | Typical clinical profile | Main limitation |
|---|---|---|
| Vardenafil | Short-acting PDE5 inhibition for erectile dysfunction; sexual stimulation remains necessary | May cause headache, flushing, nasal congestion, indigestion, or dizziness |
| Sildenafil | Similar PDE5 mechanism with established use in erectile dysfunction | Food may delay onset; visual symptoms can occur |
| Tadalafil | Longer-lasting PDE5 activity, which may suit less time-specific sexual activity | Back pain, muscle aches, headache, and prolonged medicine exposure can occur |
| Avanafil | PDE5 inhibition with a comparatively rapid clinical profile for some users | Availability, interactions, and individual response still determine suitability |
Vilitra should not be described as an imitation of sildenafil. Vardenafil and sildenafil are different active substances, even though both inhibit PDE5. Tadalafil may suit a person who wants a longer window, while a shorter-acting option may be preferred when sexual activity is more specifically planned.
Clinical guidelines from NICE and the European Association of Urology (EAU) place PDE5 inhibitors among standard pharmacological options for erectile dysfunction, with selection guided by patient preference, contraindications, interactions, and response rather than by the assumption that one substance is strongest for everyone [3].
Several avoidable patterns reduce the chance of a satisfactory response:
A missed planned dose should not be replaced by an extra dose later. If the medicine repeatedly causes headache, flushing, or poor response, the regimen needs review rather than unsupervised escalation.
Specific situations requiring medical review include:
Vardenafil can interact with medicines that lower blood pressure. The risk is greater when several vasodilating treatments are used together. The product should also be avoided in men under 18 because it is intended for adult erectile dysfunction.
Vilitra is intended for adult men with erectile dysfunction. The regimen for the chosen strength should be confirmed with a healthcare professional before starting. Seek medical assessment if erectile dysfunction appears suddenly, worsens quickly, or occurs with chest discomfort.
The most frequent reactions associated with PDE5 inhibitors involve blood-vessel relaxation and changes in smooth-muscle activity. Headache, facial flushing, nasal congestion, indigestion, and dizziness are recognised effects of vardenafil-class treatment.
Other possible effects include:
Headache is often more noticeable when the medicine is combined with alcohol, dehydration, heat, or another blood-pressure-lowering treatment. Drinking water and avoiding strenuous activity while dizzy can help reduce immediate discomfort.
Seek urgent medical attention for an erection lasting more than four hours, sudden loss of vision, sudden loss of hearing, fainting, severe chest pain, or a serious allergic reaction. Priapism, which is a prolonged and potentially painful erection, can damage erectile tissue if treatment is delayed.
One practical detail is easy to miss: chest pain after taking a PDE5 inhibitor must not be treated with nitrate medication unless emergency clinicians specifically direct the treatment. The combination can produce a dangerous fall in blood pressure.
A physician generally begins by identifying whether erectile dysfunction is occasional or persistent. Recurrent symptoms can be associated with diabetes, hypertension, high cholesterol, obesity, smoking, depression, or cardiovascular disease.
Doctors also ask about medicines. Antidepressants, some blood-pressure treatments, finasteride, opioid medicines, and sedatives can affect sexual function. Treating the cause may improve erections more reliably than repeatedly increasing the dose of a PDE5 inhibitor.
Clinical practice shows that expectations strongly affect satisfaction. A patient may judge the tablet too quickly, take it after a heavy meal, combine it with substantial alcohol, or expect an automatic erection. These factors can make a pharmacologically suitable treatment appear ineffective.
A further point concerns cardiovascular fitness. Sexual activity places physical demand on the heart, so men with unstable cardiac symptoms require assessment before using any PDE5 inhibitor.
Store Vilitra tablets in a dry place at ordinary room temperature, away from excessive heat, moisture, and direct sunlight. Keep them in a secure place that children cannot access, especially when travelling. The WHO describes appropriate medicine storage as protection from heat, moisture, light, and accidental access; its medicines-safety material was updated in 2023.
When travelling, avoid leaving tablets in a parked vehicle or luggage exposed to strong heat. Avoid a bathroom with frequent steam, and keep the medicine with other personal medicines rather than placing it loosely in an unmarked container.
Alcohol can worsen dizziness, flushing, headache, and low blood pressure during PDE5 inhibitor treatment. It can also reduce sexual response and make erectile dysfunction more difficult to manage. The FDA’s vardenafil information, reviewed in 2020, warns that blood-pressure effects and dizziness deserve attention when other vasodilating influences are present.
A small amount may be tolerated differently from heavy drinking, but individual response varies. Avoid alcohol completely if the medicine has already caused light-headedness, faintness, or a fast heartbeat.
Vilitra is intended for adult men with erectile dysfunction and should not be used by people under 18. Erectile difficulties in adolescents require a different medical assessment, because the causes and treatment decisions are not the same as in adult vascular erectile dysfunction. EMA product information for vardenafil, dated 2018, restricts this treatment approach to the adult indication.
Do not give the tablets to another person, even if the symptoms appear similar. A medicine prescribed for one adult should not be shared with a teenager or child.
A PDE5 inhibitor may begin to support erectile response within a relatively short period after dosing, but the timing varies with the individual, food intake, stimulation, circulation, and other medicines. It does not work without sexual arousal. FDA vardenafil prescribing information reviewed in 2020 describes the medicine as supporting the erectile response during sexual stimulation rather than producing an automatic erection.
A first unsuccessful attempt does not prove that the treatment cannot work. Heavy food, alcohol, insufficient stimulation, anxiety, or incorrect timing can all reduce the apparent response. Repeated lack of benefit calls for a treatment review rather than an additional unsupervised dose.
Vilitra tablets may be taken with or without food, but a heavy high-fat meal can delay the onset of some PDE5 inhibitors. A lighter meal may make the timing more predictable. NICE guidance on erectile dysfunction, published in 2019, supports discussing administration and treatment response as part of individualised PDE5 inhibitor use.
Taking the tablet with water is practical. Avoid using a large meal and substantial alcohol as a test of whether the medicine works, because both can interfere with the sexual response and increase adverse effects.
Vilitra is generally used according to the prescribed treatment plan rather than as a fixed antibiotic-style course. Some adults use a PDE5 inhibitor intermittently, while others require repeated treatment over a longer period. The FDA’s vardenafil prescribing information, reviewed in 2020, supports use according to individual response, contraindications, and dosing limits.
Long-term use may be considered when the medicine remains suitable, the person has no new contraindications, and cardiovascular or interacting medicines are reviewed periodically. Do not increase frequency, combine PDE5 inhibitors, or continue despite visual symptoms, chest pain, fainting, or prolonged erection.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Store Vilitra tablets in a dry place at ordinary room temperature, away from excessive heat, moisture, and direct sunlight. Keep them in a secure place that children cannot access, especially when travelling. The WHO describes appropriate medicine storage as protection from heat, moisture, light, and accidental access; its medicines-safety material was updated in 2023.
When travelling, avoid leaving tablets in a parked vehicle or luggage exposed to strong heat. Avoid a bathroom with frequent steam, and keep the medicine with other personal medicines rather than placing it loosely in an unmarked container.
Vilitra is generally used according to the prescribed treatment plan rather than as a fixed antibiotic-style course. Some adults use a PDE5 inhibitor intermittently, while others require repeated treatment over a longer period. The FDA’s vardenafil prescribing information, reviewed in 2020, supports use according to individual response, contraindications, and dosing limits.
Long-term use may be considered when the medicine remains suitable, the person has no new contraindications, and cardiovascular or interacting medicines are reviewed periodically. Do not increase frequency, combine PDE5 inhibitors, or continue despite visual symptoms, chest pain, fainting, or prolonged erection.
